(1R,2R,4S,5S,7s)-9-Methyl-3-oxa-9-azatricyclo[3.3.1.0~2,4~]nonan-7-ol hydrochloride (1:1)(CAS: 85700-55-6)

This compound falls under the scope of regulatory guidelines such as the Globally Harmonized System of Classification and Labelling of Chemicals (GHS), REACH regulations, and FDA/EPA requirements. It must comply with specific criteria for hazard communication, registration, and environmental protection. Manufacturers and distributors should follow the guidelines for proper labeling and documentation.

Yes, alternative reagents and isomers such as (1S,2S,4R,5R,7s)-9-Methyl-3-oxa-9-azatricyclo[3.3.1.0~2,4~]nonan-7-ol hydrochloride or other synthetic precursors can be used. These alternatives offer similar functionalities and can be sourced from various suppliers, providing flexibility in synthesis.

There is increasing interest in this compound due to its unique chemical properties and applications in medicinal chemistry. Research trends indicate growing exploration in its use as a pharmaceutical intermediate and in developing new drug candidates. Market trends show steady demand, driven by its potential in various therapeutic areas.

Waste containing this compound should be collected and disposed of in accordance with local and international regulations. Proper incineration or professional waste disposal methods should be used. Ensure that all handling and disposal procedures comply with environmental protection standards to minimize ecological impact.